Cargando…
Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
During advanced vasodilatory shock, arginine vasopressin (AVP) is increasingly used to restore blood pressure and thus to reduce catecholamine requirements. The AVP-related rise in mean arterial pressure is due to systemic vasoconstriction, which, depending on the infusion rate, may also reduce coro...
Autores principales: | Asfar, Pierre, Radermacher, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750154/ https://www.ncbi.nlm.nih.gov/pubmed/19664189 http://dx.doi.org/10.1186/cc7954 |
Ejemplares similares
-
Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008) -
Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
por: Bracht, Hendrik, et al.
Publicado: (2007) -
Vasopressin and its analogues in shock states: a review
por: Demiselle, Julien, et al.
Publicado: (2020) -
Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
por: Fage, Nicolas, et al.
Publicado: (2023) -
Nitric oxide inhibition sustains vasopressin-induced vasoconstriction.
por: Dworkin, M. J., et al.
Publicado: (1995)